Financhill
Sell
24

LENZ Quote, Financials, Valuation and Earnings

Last price:
$27.85
Seasonality move :
-9.52%
Day range:
$27.65 - $29.02
52-week range:
$16.54 - $50.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
44.50x
P/B ratio:
4.50x
Volume:
499K
Avg. volume:
1.1M
1-year change:
-22.13%
Market cap:
$873M
Revenue:
--
EPS (TTM):
-$2.11

Earnings Data

Next earnings date for LENZ
Mar 18
2026
Most recent earnings per share
-$0.59
Beat by $0.10
(Nov 5/2025)
Consensus Estimate
-$0.69
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LENZ Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/18/2026 Q4 $1.4M -- -- -$0.94 --
11/05/2025 Q3 $4.6M $12.5M -$0.59 -$0.69 $0.10
07/30/2025 Q2 $714.3K $5M -$0.53 -$0.54 $0.01
05/08/2025 Q1 -- -- -$0.53 -$0.32 -$0.21
03/19/2025 Q4 -- -- -$0.46 -$0.40 -$0.06
11/06/2024 Q3 -- -- -$0.38 -$0.43 $0.05
08/14/2024 Q2 -- -- -$0.40 -$0.67 $0.27
03/31/2024 Q1 -- -- -$3.53 -- --
12/31/2023 Q4 -- -- -$84.29 -- --
09/30/2023 Q3 -- -- -$9.62 -- --
06/30/2023 Q2 -- -- -$7.53 -- --
03/31/2023 Q1 -- -- -$6.50 -- --
12/31/2022 Q4 -- -- -$3.09 -- --
09/30/2022 Q3 -- -- -$3.13 -- --
06/30/2022 Q2 -- -- -$3.42 -- --
03/31/2022 Q1 -- -- -$3.39 -- --
12/31/2021 Q4 -- -- -$2.29 -- --
09/30/2021 Q3 -- -- -$1.76 -- --
06/30/2021 Q2 -- -- -$2.19 -- --
03/31/2021 Q1 -- -- -$2.38 -- --
12/31/2020 Q4 -- -- -$7.66 -- --
09/30/2020 Q3 -- -- -$0.41 -- --
06/30/2020 Q2 -- -- -$0.16 -- --
03/31/2020 Q1 -- -- -$0.02 -- --

LENZ Therapeutics, Inc. Earnings Questions

  • How Much did LENZ Therapeutics, Inc. Generate in Revenue Last Quarter?

    LENZ Therapeutics, Inc. reported $12.5M worth of top line sales in its most recent quarter.

  • Did LENZ Therapeutics, Inc. Beat Earnings Last Quarter?

    LENZ Therapeutics, Inc. announced earnings per share of -$0.59 which represents a beat of analyst forecast a -$0.69 per share.

  • Is LENZ Therapeutics, Inc. Profitable?

    LENZ Therapeutics, Inc. reported $12.4M that represents $0.43 per share over the last quarter.

  • What is the Analyst Consensus for LENZ Therapeutics, Inc. EPS Next Year?

    LENZ Therapeutics, Inc.'s earnings are forecast to decrease from -$2.34 per share to -$1.80 per share next year representing a decrease of -10.13%.

  • When is LENZ Therapeutics, Inc.'s Earnings Date?

    LENZ Therapeutics, Inc.'s next earnings date is March 18, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Sell
44
PSTG alert for Dec 5

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
69
ASTS alert for Dec 5

AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock